Matches in SemOpenAlex for { <https://semopenalex.org/work/W4207076893> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W4207076893 endingPage "349" @default.
- W4207076893 startingPage "344" @default.
- W4207076893 abstract "Coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/2019-nCoV). Though many classes of drugs have been advocated/used for the treatment of this disease, vaccines are being targeted for its ultimate prevention. Indian Government has approved Covishield (ChAdOx1 nCoV19 Corona Virus Vaccine-Recombinant) for restricted use in emergency circumstances.This study is aimed at evaluating the safety profile of the Covishield vaccine among healthcare workers in a tertiary care hospital.All Adverse Drug Reactions (ADRs) reported to the ADR monitoring centre by healthcare workers who received the Covishield vaccine during the study period of 3 months were analysed on various parameters, and the assessment was done using the WHO-UMC scale.During the study period, a total of 1216 beneficiaries were vaccinated with 1st dose of Covishield, and out of these, 727 beneficiaries also received 2nd dose of the vaccine. Out of the 1216 beneficiaries vaccinated, 69 ADRs were reported in 24 healthcare workers. The most common ADR reported was fever (24.64%), followed by myalgia (18.84%). No death or any serious anaphylactic reaction was observed. None of the healthcare workers experienced any adverse event during the observation period of 30 minutes. Serious reactions were reported in 4 healthcare workers as per the Pharmacovigilance Programme of India (PvPI) criteria of serious AEFI. 92% of healthcare workers recovered from ADRs during the study period. 84% of ADRs were classified as probable as per the WHO-UMC scale.As per the Government of India directives, all the healthcare workers in the institute were encouraged to take both doses of the Covishield vaccine. The beneficiaries were kept under observation for 30 minutes and monitored for any adverse drug reaction following vaccination. The vaccine was found to be safe with a very low incidence of ADRs." @default.
- W4207076893 created "2022-01-26" @default.
- W4207076893 creator A5011931203 @default.
- W4207076893 creator A5028390171 @default.
- W4207076893 creator A5033198954 @default.
- W4207076893 creator A5048407733 @default.
- W4207076893 creator A5072439986 @default.
- W4207076893 date "2022-11-01" @default.
- W4207076893 modified "2023-10-16" @default.
- W4207076893 title "ADR Profile of the Covishield Vaccine Among Healthcare Workers in a Tertiary Care Teaching Hospital in India" @default.
- W4207076893 cites W3010699833 @default.
- W4207076893 cites W3014051579 @default.
- W4207076893 cites W3016143592 @default.
- W4207076893 cites W3027138240 @default.
- W4207076893 cites W3041319886 @default.
- W4207076893 cites W3042833857 @default.
- W4207076893 cites W3111590711 @default.
- W4207076893 cites W3147435343 @default.
- W4207076893 doi "https://doi.org/10.2174/1574886317666220113101815" @default.
- W4207076893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35049437" @default.
- W4207076893 hasPublicationYear "2022" @default.
- W4207076893 type Work @default.
- W4207076893 citedByCount "2" @default.
- W4207076893 countsByYear W42070768932022 @default.
- W4207076893 countsByYear W42070768932023 @default.
- W4207076893 crossrefType "journal-article" @default.
- W4207076893 hasAuthorship W4207076893A5011931203 @default.
- W4207076893 hasAuthorship W4207076893A5028390171 @default.
- W4207076893 hasAuthorship W4207076893A5033198954 @default.
- W4207076893 hasAuthorship W4207076893A5048407733 @default.
- W4207076893 hasAuthorship W4207076893A5072439986 @default.
- W4207076893 hasConcept C126322002 @default.
- W4207076893 hasConcept C160735492 @default.
- W4207076893 hasConcept C162324750 @default.
- W4207076893 hasConcept C194828623 @default.
- W4207076893 hasConcept C197934379 @default.
- W4207076893 hasConcept C3020329203 @default.
- W4207076893 hasConcept C50522688 @default.
- W4207076893 hasConcept C512399662 @default.
- W4207076893 hasConcept C57658597 @default.
- W4207076893 hasConcept C71924100 @default.
- W4207076893 hasConceptScore W4207076893C126322002 @default.
- W4207076893 hasConceptScore W4207076893C160735492 @default.
- W4207076893 hasConceptScore W4207076893C162324750 @default.
- W4207076893 hasConceptScore W4207076893C194828623 @default.
- W4207076893 hasConceptScore W4207076893C197934379 @default.
- W4207076893 hasConceptScore W4207076893C3020329203 @default.
- W4207076893 hasConceptScore W4207076893C50522688 @default.
- W4207076893 hasConceptScore W4207076893C512399662 @default.
- W4207076893 hasConceptScore W4207076893C57658597 @default.
- W4207076893 hasConceptScore W4207076893C71924100 @default.
- W4207076893 hasIssue "4" @default.
- W4207076893 hasLocation W42070768931 @default.
- W4207076893 hasLocation W42070768932 @default.
- W4207076893 hasOpenAccess W4207076893 @default.
- W4207076893 hasPrimaryLocation W42070768931 @default.
- W4207076893 hasRelatedWork W1970223156 @default.
- W4207076893 hasRelatedWork W2021673836 @default.
- W4207076893 hasRelatedWork W2050282066 @default.
- W4207076893 hasRelatedWork W2170418897 @default.
- W4207076893 hasRelatedWork W2374781999 @default.
- W4207076893 hasRelatedWork W2467454365 @default.
- W4207076893 hasRelatedWork W2785010619 @default.
- W4207076893 hasRelatedWork W3160380287 @default.
- W4207076893 hasRelatedWork W4207076893 @default.
- W4207076893 hasRelatedWork W4299555276 @default.
- W4207076893 hasVolume "17" @default.
- W4207076893 isParatext "false" @default.
- W4207076893 isRetracted "false" @default.
- W4207076893 workType "article" @default.